
FDA approves remdesivir to treat COVID-19
The Food and Drug Administration has approved remdesivir for the treatment of the coronavirus, and it comes as some cities across the country are seeing spikes in COVID-19 cases. Janet Shamlian reports.
Watch CBS News
The Food and Drug Administration has approved remdesivir for the treatment of the coronavirus, and it comes as some cities across the country are seeing spikes in COVID-19 cases. Janet Shamlian reports.
U.S. drugstore chain says continuing pandemic only heightens its seasonal need for workers at its 10,000 pharmacies.
The race for a COVID-19 vaccine is heating up as cases rise worldwide. The chair of the U.K. Vaccine Taskforce says there's a slim chance a vaccine may be ready by Christmas. CBS News foreign correspondent Charlie D'Agata reports.
A 25-year-old man in Nevada is the first confirmed case of a patient in the U.S. who recovered from a coronavirus infection and then got infected a second time from a distinct strain of the virus. Dr. Dyan Hes, founder of Gramercy Pediatrics, joins CBSN to talk about the risk of reinfection, plus another pause in one of the vaccine trials and other coronavirus news.
Dr. Bob Lahita is a professor of medicine at New York Medical College and chairman of medicine at St. Joseph's Health Care System. He joins CBSN's "Red & Blue" to discuss President Trump's recovery, the vaccine development process and why it's highly unlikely we'll see a coronavirus vaccine before Election Day.
Moderna's CEO said his company's coronavirus vaccine won't be ready for distribution to the general population until next spring. Nikki Battiste reports.
Top infectious disease experts delivered testimony about the U.S. pandemic response before a Senate committee Wednesday. Dr. Fauci went back and forth with Rand Paul, and accused the senator of distorting information. Mola Lenghi reports.
As the U.S. death toll from the coronavirus pandemic nears the 200,000 mark, emergency care physician Dr. Ron Elfenbein joined CBSN to discuss the heartbreaking milestone, what Americans could be doing right now to slow the spread, and what he expects in the months ahead.
President Trump has been publicly disputing the statements of his top medical advisers about the coronavirus vaccine timeline, as he faces more criticism from a former task force aide. CBS News White House correspondent Weijia Jiang joins CBSN to explain the latest developments.
President Trump is at odds with the nation's top health officials over the timing of coronavirus vaccine. It comes as a former adviser Vice Pence Mike Pence who was on the Coronavirus Task Force criticized the administration's response to the pandemic. CBS News White House correspondent Paula Reid joins Lana Zak to discuss.
According to Johns Hopkins University, 70% to 90% of Americans would need to have coronavirus antibodies for herd immunity to be achieved.
As the global race for a coronavirus vaccine continues, China, Russia and the United Arab Emirates are allowing their citizens to get vaccinated with an experimental vaccine before clinical trials wrap up. Internal medicine specialist and immunologist Dr. Neeta Ogden joined CBSN to discuss more.
Democratic presidential nominee Joe Biden on Wednesday gave a speech on the coronavirus vaccine development in Wilmington, Delaware. Before laying out his own plans, Biden warned against leaving the distribution of a potential vaccine in the hands of the Trump administration. CBSN Political Reporter Caitlin Huey-Burns joins Lana Zak with the details of Biden's speech, including his comments on implementing a national mask mandate.
CDC director Robert Redfield contradicted President Trump during sworn testimony Wednesday. Redfield said face masks are an effective tool in fighting the coronavirus and a vaccine would not be widely available until sometime next year. Paula Reid reports.
President Trump delivered a speech in Pennsylvania today honoring the victims of the September 11th terrorist attacks. CBS News White House correspondent Paula Reid joins CBSN to recap his remarks and talk about some of the latest news from Washington.
Experts say the FDA has a rigorous process for vetting any COVID-19 treatment, though there is a loophole.
AstraZeneca announced it is pausing its phase 3 trial of a possible COVID-19 vaccine after one participant came down with an unexplained illness. Dr. Matthew Heinz joins CBSN for a closer look at what this means, plus the special concerns surrounding the coming flu season and when people should get their flu shots.
Drugmaker AstraZeneca paused its clinical trial of a COVID-19 vaccine to investigate a possible severe adverse reaction in one of the participants. This comes as the U.S. death toll from the coronavirus nears 190,000. CBS News' Elise Preston reports on the latest developments, and Dr. Neeta Ogden, an internal medicine doctor and immunologist, joined CBSN to discuss what it all means.
Democratic presidential candidate Joe Biden says he would want to hear from scientists, not just President Trump, about the safety of any potential coronavirus vaccine. President Trump says Biden's comments "undermine science." CBS News White House correspondent Paula Reid joins CBSN with more on that plus the latest pushback over a report in "The Atlantic" that the president disparaged soldiers killed in combat, and the president's plans to release a list of potential Supreme Court nominees.
President Trump is denying claims that he called fallen U.S. servicemen "suckers" and "losers" for dying in World War I. The story first broke in The Atlantic magazine, but key claims have since been corroborated by other outlets including Fox News. The Associated Press White House reporter Zeke Miller joins CBSN's Lana Zak to talk about this latest scandal's potential impact on the November election.
Former FDA Commissioner Scott Gottlieb says Americans are "exhausted" by coronavirus mitigation efforts, warning vigilance to fight the virus.
Russia says it will approve the first COVID-19 vaccine next week even though the Phase 3 trial, to prove if it's safe and effective, is not complete. Dr. Bob Lahita joins CBSN's Anne-Marie Green to discuss the concerns.
Researchers at the University of Oxford said Monday that a candidate vaccine for the coronavirus had positive clinical trial results. Dr. Bob Lahita joined CBSN to discuss.
Novavax is the latest company to get $1.6 billion in federal funding to develop and distribute a coronavirus vaccine by early 2021. This comes as cases surge in states like Texas and Florida. Internal medicine specialist, Dr. Neeta Ogden joins CBSN to discuss the latest details
The National Institutes of Health director said "people are a little uneasy about the government calling the shots here"
Vance has described his longtime friendship with Kirk, who was also a key ally in his political rise.
Kash Patel and his deputy Dan Bongino are challenging the FBI's fierce allegiance to message control.
President Trump says getting rid of a quarterly reporting requirement for public companies would lower costs and help businesses.
"We have a framework for a TikTok deal," Treasury Secretary Scott Bessent said after talks with Chinese officials in Spain.
CBS News looked at the cost of producing coal, gas, nuclear, wind and solar energy to determine which is the cheapest.
President Trump announced Monday the U.S. military has carried out a second strike on alleged Venezuelan "narcoterrorists."
Experts say Americans shouldn't expect a further decline in mortgage rates immediately after the Fed's September meeting.
The suspect in the assassination of Charlie Kirk is under special watch in a Utah jail, days after he allegedly shot and killed the 31-year-old conservative activist.
A range of companies and other organizations are sanctioning — and sometimes firing — workers over their public comments about Charlie Kirk. They may have little recourse.